Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy
Clinical trial NCT06478862 · TERMINATED
Trial details
- NCT number
- NCT06478862
- Sponsor
- Lipomedix Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-13
- Primary completion
- 2026-01-02
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.